A new CCC-NHC pincer ligand precursor architecture based
on 1,3-bis(N-alkylbenzimidazole)benzene
has been synthesized and metalated using Ag2O, forming
a homobimetallic Ag complex with a metal to ligand ratio of 1:1. The
Ag complex was treated with either [Rh(COD)Cl]2 or Rh(COD)2OTf and NBu4I to yield a homobimetallic Rh complex
by transmetalation. The Rh complexes were characterized, and an X-ray
structure is reported. Their catalytic activity in the hydrosilylation
of phenylacetylene is reported.
A report that demonstrated an efficient methodology for the arylation of imidazoles has been extended to bis(N-heterocyclic) compounds. Using bis(aryl) iodonium salts provides high-yielding access to CCC-NHC ligand precursors in a single step. Examples of arylation using various iodonium salts are reported herein with an investigation into the factors governing their relative rate of reactivity. The metalation of one of these compounds using Zr(NMe2)4 and its subsequent treatment with [Pt(COD)Cl2] to yield a transmetalated product are reported.
The coupling of N-heterocyclic azoles (imidazoles, benzimidazoles, triazoles) to bromobenzenes (1,2-; 1,3-; or 1,4) in a step-wise, sequential manner was accomplished by manipulation of reaction time and stoichiometry, which provided straightforward access to unsymmetrical bis(azolium) salts in only three isolation steps from commercially-available starting materials. Eight mono(azole) substituted bromobenzenes, four mono(azolium)bromobenzene salts, twelve unsymmetrical bis(azole)benzenes, and fourteen unsymmetrical bis(azolium) salts, which are precursors for pincer ligand complexes, are reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.